{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:40:51Z","timestamp":1790077251947,"version":"4.0.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ejogrb.2017.06.047","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T02:32:50Z","timestamp":1499481170000},"page":"61-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Update on medical treatment of uterine fibroids"],"prefix":"10.1016","volume":"216","author":[{"given":"F\u00e1tima","family":"Faustino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Martinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"\u00c1guas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2017.06.047_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2011.01.001","article-title":"Figo working group on menstrual disorders: FIGO classification system for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"Munro","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"10.1016\/j.ejogrb.2017.06.047_bib0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1083-3188(96)70030-X","article-title":"Uterine myomas in adolescents: case reports and a review of the literature","volume":"9","author":"Fields","year":"1996","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ajcp\/94.4.435","article-title":"The frequency of uterine leiomyomas","volume":"94","author":"Cramer","year":"1990","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.ejogrb.2017.06.047_bib0020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.AOG.0000136079.62513.39","article-title":"Vlahos uterine myomas: an overview of development, clinical features, and management","volume":"104","author":"Wallach","year":"2004","journal-title":"Obstetrics Gynecol"},{"issue":"March-April (2)","key":"10.1016\/j.ejogrb.2017.06.047_bib0025","first-page":"152","article-title":"AAGL practice report: practice guidelines for the diagnosis and management of submucous leiomyomas","volume":"19","year":"2012","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0030","series-title":"Consenso sobre Miomas Uterinos da Sociedade Portuguesa de Ginecologia","author":"\u00c1guas","year":"2013"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejogrb.2010.05.012","article-title":"The burden of uterine fibroids in five European countries","volume":"152","author":"Downes","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.ejogrb.2017.06.047_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/03007995.2014.982246","article-title":"Contemporary management of uterine fibroids: focus on emerging medical treatments","volume":"31","author":"Singh","year":"2015","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0045","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ajog.2006.02.020","article-title":"Health care resource use for uterine fibroid tumors in the United States","volume":"195","author":"Flynn","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2017.06.047_bib0050","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/GCO.0b013e328359f10a","article-title":"Review of nonsurgical\/minimally invasive treatments for uterine fibroids","volume":"24","author":"van der Kooij","year":"2012","journal-title":"Curr Opin Obstet Gynecol."},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0055","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijgo.2005.03.013","article-title":"SOGC clinical practice guidelines. Uterine fibroid embolization (UFE)","volume":"89","author":"Society of Obstetricians and Gynaecologists of Canada","year":"2005","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0060","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejogrb.2012.07.030","article-title":"Therapeutic management of uterine fibroid tumors: updated French guidelines","volume":"165","author":"Marret","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.AOG.0000149156.07061.1f","article-title":"Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial","volume":"105","author":"Pron","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0070","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1471-0528.2007.01526.x","article-title":"A UK multicentre retrospective cohort study comparing hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids (HOPEFUL study): main results on medium-term safety and efficacy","volume":"114","author":"Dutton","year":"2007","journal-title":"BJOG: Int J Obstetrics Gynaecol"},{"issue":"396\u2013418","key":"10.1016\/j.ejogrb.2017.06.047_bib0075","first-page":"19","article-title":"The management of uterine leiomyomas","volume":"25","author":"Lefebvre","year":"2003","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1074-3804(98)80034-0","article-title":"Pregnancy outcome after laparoscopic electromyolysis","volume":"5","author":"Vilos","year":"1998","journal-title":"J Am Assoc Gynecologic Laparoscopists"},{"issue":"2 Pt 1","key":"10.1016\/j.ejogrb.2017.06.047_bib0085","first-page":"387","article-title":"ACOG practice bulletin. Alternatives to hysterectomy in the management of leiomyomas","volume":"112","author":"American College of Obstetricians and Gynecologists","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijgo.2010.08.009","article-title":"A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia","volume":"112","author":"Sayed","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0095","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1080\/01443610400009543","article-title":"Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study","volume":"24","author":"Venkatachalam","year":"2004","journal-title":"J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2017.06.047_bib0100","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.fertnstert.2009.09.048","article-title":"Levonorgestrel-releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a significant regression in the uterine and leiomyoma volumes","volume":"94","author":"Murat Naki","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejogrb.2006.07.018","article-title":"Presurgical short term treatment of uterine fibroids with different doses of cetrorelix acetate: a double-blind, placebo-controlled multicenter study","volume":"134","author":"Engel","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0110","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/humrep\/13.6.1660","article-title":"Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist cetrorelix","volume":"13","author":"Felberbaum","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0115","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1471-0528.2004.00504.x","article-title":"Rapid reduction of leiomyoma volume during treatment with the GnRH antagonist ganirelix","volume":"112","author":"Flierman","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0120","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000010118","article-title":"Short-term treatment of uterine fibromyomas with danazol","volume":"47","author":"De Leo","year":"1999","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/09513598709082692","article-title":"Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis","volume":"1","author":"Telimaa","year":"1987","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0130","first-page":"CD000547","article-title":"Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids","author":"Lethaby","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0135","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0015-0282(16)60723-9","article-title":"Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography","volume":"51","author":"Donnez","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0140","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/humrep\/14.1.44","article-title":"Laparoscopic myomectomy in premenopausal women with and without preoperative treatment using gonadotrophin-releasing hormone analogues","volume":"14","author":"Campo","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0145","first-page":"CD010241","article-title":"Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding","author":"Tan","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0150","first-page":"CD010854","article-title":"Add-back therapy with GnRH analogues for uterine fibroids","volume":"3","author":"Moroni","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0155","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0015-0282(02)04761-1","article-title":"Successful treatment of a symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor","volume":"79","author":"Shozu","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0160","first-page":"CD005287","article-title":"Selective estrogen receptor modulators(SERMs) for uterine leiomyomas","volume":"10","author":"Deng","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ejogrb.2017.06.047_bib0165","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1016\/j.fertnstert.2010.07.852","article-title":"exhibits antiestrogenic effects in human uterine leiomyoma cells","volume":"94","author":"Halder","year":"2010","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ejogrb.2017.06.047_bib0170","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.fertnstert.2009.08.065","article-title":"Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells","volume":"94","author":"Zhang","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0175","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejogrb.2012.07.023","article-title":"Progesterone and progesterone receptor modulators in the management of symptomatic uterine fibroids","volume":"165","author":"Talaulikar","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0180","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.fertnstert.2011.08.021","article-title":"Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety","volume":"96","author":"Bouchard","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0185","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.mce.2012.02.021","article-title":"The imminent dawn of SPRMs in obstetrics and gynecology","volume":"358","author":"Chabbert-Buffet","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"1 Pt 1","key":"10.1016\/j.ejogrb.2017.06.047_bib0190","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9378(95)90077-2","article-title":"Progesterone: a critical role in the pathogenesis of uterine myomas","volume":"172","author":"Rein","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0195","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1055\/s-2007-1016336","article-title":"Growth factors and cytokines in uterine leiomyomas","volume":"14","author":"Andersen","year":"1996","journal-title":"Semin Reprod Endocrinol"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0200","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-0030-1251476","article-title":"Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder","volume":"28","author":"Chegini","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0205","first-page":"4092","article-title":"Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment","volume":"83","author":"Englund","year":"1998","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0210","first-page":"1876","article-title":"Estrogen receptor gene expression in human uterine leiomyomata","volume":"80","author":"Brandon","year":"1995","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0215","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0002-9378(93)90135-6","article-title":"Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas","volume":"169","author":"Brandon","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0220","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0225","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/1097-4652(2000)9999:999<000::AID-JCP1040>3.0.CO;2-E","article-title":"17-Estradiol elicits an autocrine leiomyoma cell proliferation: evidence for a stimulation of protein kinase-dependent pathway","volume":"186","author":"Barbarisi","year":"2001","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0230","first-page":"293","article-title":"Increased expression of Bcl-2 protein in human uterine leiomyoma and its up-regulation by progesterone","volume":"82","author":"Matsuo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0235","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1210\/jc.2005-2379","article-title":"A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells","volume":"91","author":"Chen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0240","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/humupd\/dmh019","article-title":"Sex steroidal regulation of uterine leiomyoma growth and apoptosis","volume":"10","author":"Maruo","year":"2004","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0245","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/humrep\/deh146","article-title":"Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells","volume":"19","author":"Yamada","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0250","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/er.2005-0001","article-title":"Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis","volume":"26","author":"Chwalisz","year":"2005","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.ejogrb.2017.06.047_bib0255","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/humupd\/dmi002","article-title":"Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications","volume":"11","author":"Chabbert-Buffet","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0260","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s12325-012-0042-8","article-title":"Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids","volume":"29","author":"Talaulikar","year":"2012","journal-title":"Adv Ther"},{"issue":"2","key":"10.1016\/j.ejogrb.2017.06.047_bib0265","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejogrb.2012.07.023","article-title":"Progesterone and progesterone receptor modulators in the management of symptomatic uterine fibroids","volume":"165","author":"Talaulikar","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0270","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0275","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0280","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long-term treatment of uterine fibroids with ulipristal acetate","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil Steril"},{"issue":"February (2)","key":"10.1016\/j.ejogrb.2017.06.047_bib0285","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.fertnstert.2014.10.038","article-title":"Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids","volume":"103","author":"Donnez","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2017.06.047_bib0290","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.fertnstert.2015.09.032","article-title":"Long-term medical management of uterine fibroids with ulipristal acetate","volume":"106","author":"Donnez","year":"2016","journal-title":"Fertil Steril"},{"issue":"November (5)","key":"10.1016\/j.ejogrb.2017.06.047_bib0295","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.fertnstert.2014.07.1253","article-title":"First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids","volume":"102","author":"Luyckx","year":"2014","journal-title":"Fertil Steril."}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121151730324X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121151730324X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:40:38Z","timestamp":1759556438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030121151730324X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":59,"alternative-id":["S030121151730324X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2017.06.047","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on medical treatment of uterine fibroids","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2017.06.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}